Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 10/20 | 0.40 |
| ▸ | ADRA1D | P25100 | 9/20 | 0.40 |
| ▸ | ADRA1B | P35368 | 9/20 | 0.40 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18764271 | 1.00 | HDAC4 (0.44) | HDAC4ADRA1AADRA1DADRA1BPDE7A | |
| SCHEMBL624164 | 0.94 | ADRA1A (0.41) | HDAC4ADRA1AADRA1DADRA1BTSHR | |
| SCHEMBL10528035 | 0.90 | ADRA1A (0.43) | HDAC4ADRA1AADRA1DADRA1BTSHR | |
| SCHEMBL31459412 | 0.90 | ADRA1A (0.43) | HDAC4ADRA1AADRA1DADRA1BTSHR | |
| SCHEMBL19382151 | 0.83 | PDE7A (0.37) | HDAC4ADRA1AADRA1DADRA1BPDE7A | |
| SCHEMBL7657049 | 0.82 | OPRM1 (0.51) | ADRA1AADRA1DADRA1BOPRM1 | |
| Hydrochloric Acid SCHEMBL7966821 | 0.81 | OPRM1 (0.50) | ADRA1AADRA1DADRA1BOPRM1 | |
| SCHEMBL2294184 | 0.81 | ADRA1A (0.43) | HDAC4ADRA1AADRA1DADRA1BMEN1 | |
| SCHEMBL10389492 | 0.79 | ALDH1A1 (0.41) | MEN1NPC1ALDH1A1RAB9AKMT2A | |
| SCHEMBL10389491 | 0.79 | ALDH1A1 (0.41) | MEN1NPC1ALDH1A1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3845515-B1 | PRODUCTION METHOD FOR CRYSTAL OF REDUCED COENZYME Q10 HAVING EXCELLENT STABILITY | KANEKA CORP (JP) | 2025-11-12 | — | — | EP | disclosed |
| CN-112041454-B | Method for producing coenzyme Q10 | 株式会社钟化 | 2025-02-18 | — | — | CN | disclosed |
| CN-113166017-B | Process for producing reduced coenzyme Q10 crystals having excellent stability | 株式会社钟化 | 2024-03-29 | — | — | CN | disclosed |
| US-11773043-B2 | Systems and methods for producing coenzyme Q10 | Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. (CN) | 2023-10-03 | — | — | US | disclosed |
| CN-110944970-B | For the production of coenzyme Q 10 Systems and methods of (1) | 内蒙古金达威药业有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-109415744-B | Method for producing coenzyme Q10 | 株式会社钟化 | 2023-04-28 | — | — | CN | disclosed |
| US-11498893-B2 | Production method for crystal of reduced coenzyme Q10 having excellent stability | KANEKA CORPORATION (JP) | 2022-11-15 | — | — | US | disclosed |
| US-11453633-B2 | Production method for crystal of reduced coenzyme Q10 having excellent stability | KANEKA CORPORATION (JP) | 2022-09-27 | — | — | US | disclosed |
| US-20210355059-A1 | PRODUCTION METHOD FOR CRYSTAL OF REDUCED COENZYME Q10 HAVING EXCELLENT STABILITY | KANEKA CORPORATION (JP) | 2021-11-18 | — | — | US | disclosed |
| CN-107709567-B | Reduced coenzyme Q10Method of manufacturing (2) | 株式会社钟化 | 2021-11-02 | — | — | CN | disclosed |
| EP-1415971-A1 | METHOD OF PRODUCING REDUCED COENZYME Q10 AS OILY PRODUCT | KANEKA CORPORATION (JP) | 2004-05-06 | — | — | EP | disclosed |
| EP-1415969-A1 | METHOD OF PRODUCING REDUCED COENZYME Q10 USING SOLVENT WITH HIGH OXIDATION-PROTECTIVE EFFECT | KANEKA CORPORATION (JP) | 2004-05-06 | — | — | EP | disclosed |
| EP-1415973-A1 | METHOD OF STABILIZING REDUCED COENZYME Q10 AND METHOD OF ACIDIC CRYSTALLIZATION | KANEKA CORPORATION (JP) | 2004-05-06 | — | — | EP | disclosed |
| EP-1415972-A1 | METHOD OF PRODUCING REDUCED COENZYME Q10 | KANEKA CORPORATION (JP) | 2004-05-06 | — | — | EP | disclosed |
| EP-1415970-A1 | METHOD OF PRODUCING REDUCED COENZYME Q10 CRYSTALS WITH EXCELLENT HANDLING PROPERTIES | KANEKA CORPORATION (JP) | 2004-05-06 | — | — | EP | disclosed |
| EP-1408024-A1 | METHOD OF CRYSTALLIZING REDUCED COENZYME Q sb 10 /sb FROM AQUEOUS SOLUTION | KANEKA CORPORATION (JP) | 2004-04-14 | — | — | EP | disclosed |
| EP-0796852-B1 | Process for preparation of 5-substituted tetrazoles | TOYO KASEI KOGYO CO LTD (JP) | 2001-10-24 | — | — | EP | disclosed |
| US-6040454-A | REACTING 1-(CYANOBIPHENYLMETHYL)IMIDAZOLE DERIVATIVE WITH AN ALKALI OR ALKALINE EARTH METAL AZIDE SALT IN AN AROMATIC HYDROCARBON SOLVENT IN PRESENCE OF AN AMINE SALT | TOYO KASEI KOGYO COMPANY LIMITED (JP) | 2000-03-21 | — | — | US | disclosed |
| US-5744612-A | Process for preparation of 5- substituted tetrazoles | TOYO KASEI KOGYO COMPANY LIMITED (JP) | 1998-04-28 | — | — | US | disclosed |
| EP-0796852-A1 | Process for preparation of 5-substituted tetrazoles | Toyo Kasei Kogyo Company Limited (JP) | 1997-09-24 | — | — | EP | disclosed |